As expected, caspase-3 activity was remarkably increased in the cancer cells treated with SNCP8@st-p53pep in a dose dependent manner, while the cells treated with st-p53pep and SNCP8 alone showed similar caspase-3 activity levels to the untreated control (Fig. 4c). This evidence concerns the gene CASP3 and cancer.